UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Annals of oncology, 2018-12, Vol.29 (12), p.2334-2340

2018

Volltextzugriff (PDF)

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

BMC cancer, 2021-11, Vol.21 (1), p.1204-1204, Article 1204

2021

Volltextzugriff (PDF)

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

BMC cancer, 2021-05, Vol.21 (1), p.578-578, Article 578

2021

Volltextzugriff (PDF)

Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data

Critical reviews in oncology/hematology, 2018-12, Vol.132, p.138-144

2018

Volltextzugriff (PDF)

The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy

Breast (Edinburgh), 2018-02, Vol.37, p.114-118

2018

Volltextzugriff (PDF)

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study

ESMO open, 2023-12, Vol.8 (6), p.102041-102041, Article 102041

2023

Volltextzugriff (PDF)

A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)

Annals of oncology, 2018-10, Vol.29, p.viii89-viii89

2018

Volltextzugriff (PDF)

Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial

Annals of oncology, 2018-10, Vol.29, p.viii57-viii57

2018

Volltextzugriff (PDF)

Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report

Journal of medical case reports, 2016-06, Vol.10 (1), p.178-178, Article 178

2016

Volltextzugriff (PDF)

The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features

Haematologica (Roma), 2015-03, Vol.100 (3), p.e114-e115

2015

Volltextzugriff (PDF)

Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study

ESMO open, 2021-08, Vol.6 (4), p.100207-100207, Article 100207

2021

Volltextzugriff (PDF)

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.597-609

2020

Volltextzugriff (PDF)

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia

Leukemia, 2010-05, Vol.24 (5), p.1052-1055

2010

Volltextzugriff (PDF)

The Place of Extensive Surgery in Locoregional Recurrence and Limited Metastatic Disease of Breast Cancer: Preliminary Results

BioMed research international, 2015-01, Vol.2015 (2015), p.1-7

2015

Volltextzugriff (PDF)

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (7), p.617-628

2019

Volltextzugriff (PDF)

38P Morphological heterogeneity in ductal carcinoma in situ of the breast

Annals of oncology, 2020-05, Vol.31, p.S28-S29

2020

Volltextzugriff (PDF)

Integrating spatial and single cell transcriptomics to identify and characterize biologically driven subgroups in invasive lobular carcinoma

European journal of cancer (1990), 2024-03, Vol.200, p.113620, Article 113620

2024

Volltextzugriff (PDF)

341PFinal results of the STEM trial: SFX-01 in the treatment and evaluation of ER+ Her2- metastatic breast cancer (mBC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome

Europace (London, England), 2007-09, Vol.9 (9), p.837-843

2007

Volltextzugriff (PDF)

88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study

Annals of oncology, 2021-09, Vol.32, p.S394-S394

2021

Volltextzugriff (PDF)

Abstract P2-14-11: Mechanisms involved in hypnosis analgesia explaining potential benefits observed among breast cancer patients undergoing breast surgery

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-14-11

2019

Volltextzugriff (PDF)

Abstract P5-22-23: Electrochemotherapy : A new local therapy for cutaneous metastases of breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-22-23

2018

Volltextzugriff (PDF)

385TiPRIBOB: A study on the efficacy and safety of ribociclib in combination with letrozole in older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior systemic therapy for advanced disease

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

224PA critical appraisal of quality indicators of breast cancer treatment in Belgium

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

335 (PB-130) - Identification and calculation of quality indicators in systemic treatment in breast cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S93-S93

2018

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(45)
Humans
(33)
Female
(18)
Oncology
(17)
Breast Cancer
(15)
Biological And Medical Sciences
(13)
Middle Aged
(11)
Chemotherapy
(10)
Breast Neoplasms - Drug Therapy
(9)
Symbiosis
(9)
Adult
(8)
Aged
(8)
Frankia
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Metastasis
(8)
Plant Sciences
(8)
Cancer Therapies
(7)
Casuarina Glauca
(7)
Gene Expression
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study

Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data

The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy

Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study

A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)

Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial

Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report

The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features

Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia

The Place of Extensive Surgery in Locoregional Recurrence and Limited Metastatic Disease of Breast Cancer: Preliminary Results

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

38P Morphological heterogeneity in ductal carcinoma in situ of the breast

Integrating spatial and single cell transcriptomics to identify and characterize biologically driven subgroups in invasive lobular carcinoma

341PFinal results of the STEM trial: SFX-01 in the treatment and evaluation of ER+ Her2- metastatic breast cancer (mBC)

Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome

88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study

Abstract P2-14-11: Mechanisms involved in hypnosis analgesia explaining potential benefits observed among breast cancer patients undergoing breast surgery

Abstract P5-22-23: Electrochemotherapy : A new local therapy for cutaneous metastases of breast cancer

385TiPRIBOB: A study on the efficacy and safety of ribociclib in combination with letrozole in older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior systemic therapy for advanced disease

224PA critical appraisal of quality indicators of breast cancer treatment in Belgium

335 (PB-130) - Identification and calculation of quality indicators in systemic treatment in breast cancer

Suchergebnisse filtern